Largazole, an inhibitor of class i histone deacetylases, attenuates inflammatory corneal neovascularization

European Journal of Pharmacology

Volumn 740, Issue , 2014, Pages 619-626

  Zhou, Hongyan ^a   Jiang, Sheng ^b   Chen, Jianping ^a   Ren, Xiangrong ^a   Jin, Jiayi ^a   Su, Shao Bo ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

Angiogenesis; CNV; HDACs; Largazole

Indexed keywords

ADAMTS1 PROTEIN; ALKALI; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 1 INHIBITOR; HISTONE DEACETYLASE INHIBITOR; LARGAZOLE; THROMBOSPONDIN 1; THROMBOSPONDIN 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN; ADAM PROTEIN; ANTIINFLAMMATORY AGENT; DEPSIPEPTIDE; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; THIAZOLE DERIVATIVE; THROMBOSPONDIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA INJURY; CORNEA NEOVASCULARIZATION; DOWN REGULATION; DRUG EFFECT; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; MOUSE MODEL; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL MOTION; CORNEAL NEOVASCULARIZATION; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; METABOLISM; PHYSIOLOGY;

ADAM PROTEINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CORNEAL NEOVASCULARIZATION; DEPSIPEPTIDES; ENDOTHELIAL CELLS; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTORS; HISTONE DEACETYLASE INHIBITORS; HUMANS; MICE, INBRED BALB C; RNA, MESSENGER; THIAZOLES; THROMBOSPONDIN 1; THROMBOSPONDINS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84919448332     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.06.019     Document Type: Article

References (39)

1. N.R. Bertos, A.H. Wang, and X.J. Yang Class II histone deacetylases: structure, function, and regulation Biochem. Cell Biol. 79 2001 243 252
2. A.A. Bowers, N. West, T.L. Newkirk, A.E. Troutman-Youngman, S.L. Schreiber, O. Wiest, J.E. Bradner, and R.M. Williams Synthesis and histone deacetylase inhibitory activity of largazole analogs: alteration of the zinc-binding domain and macrocyclic scaffold Org. Lett. 11 2009 1301 1304
3. A. Braza-Boils, J. Gilabert-Estelles, L.A. Ramon, J. Gilabert, J. Mari-Alexandre, M. Chirivella, F. Espana, and A. Estelles Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis PLoS One 8 2013 e62370
4. C.M. Cox, S.L. D'Agostino, M.K. Miller, R.L. Heimark, and P.A. Krieg Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo Dev. Biol. 296 2006 177 189
5. S.E. Cress WD Histone deacetylases, transcriptional control, and cancer J. Cell. Physiol. 184 2000 1 16
6. S. Den, C. Sotozono, S. Kinoshita, and T. Ikeda Efficacy of early systemic betamethasone or cyclosporin A after corneal alkali injury via inflammatory cytokine reduction Acta Ophthalmol. Scand. 82 2004 195 199
7. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 1995 27 31
8. S. Frantz, K.A. Vincent, O. Feron, and R.A. Kelly Innate immunity and angiogenesis Circ. Res. 96 2005 15 26
9. L. Gao, M.A. Cueto, F. Asselbergs, and P. Atadja Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family J. Biol. Chem. 277 2002 25748 25755
10. J. Gilabert-Estelles, L.A. Ramon, F. Espana, J. Gilabert, V. Vila, E. Reganon, R. Castello, M. Chirivella, and A. Estelles Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems Hum. Reprod. 22 2007 2120 2127
11. K. Glunde, A.P. Pathak, and Z.M. Bhujwalla Molecular-functional imaging of cancer: to image and imagine Trends Mol. Med. 13 2007 287 297
12. S.G. Gray, and T.J. Ekstrom The human histone deacetylase family Exp. Cell Res. 262 2001 75 83
13. C.H. Ha, B.S. Jhun, H.Y. Kao, and Z.G. Jin VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis Arterioscler. Thromb. Vasc. Biol. 28 2008 1782 1788
14. C.H. Ha, W. Wang, B.S. Jhun, C. Wong, A. Hausser, K. Pfizenmaier, T.A. McKinsey, E.N. Olson, and Z.G. Jin Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis J. Biol. Chem. 283 2008 14590 14599
15. J. Hong, and H. Luesch Largazole: from discovery to broad-spectrum therapy Nat. Prod. Rep. 29 2012 449 456
16. Y. Kawano, S. Nakamura, K. Nasu, J. Fukuda, H. Narahara, and I. Miyakawa Expression and regulation of thrombospondin-1 by human endometrial stromal cells Fertil. Steril. 83 2005 1056 1059
17. K. Kerl, D. Ries, R. Unland, C. Borchert, N. Moreno, M. Hasselblatt, H. Jurgens, M. Kool, D. Gorlich, M. Eveslage, M. Jung, M. Meisterernst, and M. Fruhwald The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells BMC Cancer 13 2013 286
18. S. Li, X.A. Fu, X.F. Zhou, Y.Y. Chen, and W.Q. Chen Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy Int. J. Ophthalmol. 5 2012 726 730
19. C.C. Liang, A.Y. Park, and J.L. Guan in vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro Nat. Protoc. 2 2007 329 333
20. C.M. Lin, H. Chang, Y.H. Chen, S.Y. Li, I.H. Wu, and J.H. Chiu Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1 Int. Immunopharmacol. 6 2006 1690 1698
21. Y. Liu, L.A. Salvador, S. Byeon, Y. Ying, J.C. Kwan, B.K. Law, J. Hong, and H. Luesch Anticolon cancer activity of largazole, a marine-derived tunable histone deacetylase inhibitor J. Pharmacol. Exp. Ther. 335 2010 351 361
22. Y. Liu, Z. Wang, J. Wang, W. Lam, S. Kwong, F. Li, S.L. Friedman, S. Zhou, Q. Ren, Z. Xu, X. Wang, L. Ji, S. Tang, H. Zhang, E.L. Lui, and T. Ye A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-beta and vascular endothelial growth factor signalling Liver Int. 33 2013 504 515
23. A. Mai, S. Massa, R. Pezzi, S. Simeoni, D. Rotili, A. Nebbioso, A. Scognamiglio, L. Altucci, P. Loidl, and G. Brosch Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides J. Med. Chem. 48 2005 3344 3353
24. M. Martin, R. Kettmann, and F. Dequiedt Class IIa histone deacetylases: regulating the regulators Oncogene 26 2007 5450 5467
25. M. Martin, M. Potente, V. Janssens, D. Vertommen, J.C. Twizere, M.H. Rider, J. Goris, S. Dimmeler, R. Kettmann, and F. Dequiedt Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis Proc. Natl. Acad.Sci. U.S.A. 105 2008 4727 4732
26. S. Minucci, and P.G. Pelicci Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat. Rev. Cancer 6 2006 38 51
27. D. Mottet, A. Bellahcene, S. Pirotte, D. Waltregny, C. Deroanne, V. Lamour, R. Lidereau, and V. Castronovo Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis Circ. Res. 101 2007 1237 1246
28. A.K. Olsson, A. Dimberg, J. Kreuger, and L. Claesson-Welsh VEGF receptor signalling - in control of vascular function Nat. Rev. Mol. Cell Biol. 7 2006 359 371
29. D.Z. Qian, Y. Kato, S. Shabbeer, Y. Wei, H.M. Verheul, B. Salumbides, T. Sanni, P. Atadja, and R. Pili Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589 Clin. Cancer Res. 12 2006 634 642
30. T. Saber, D.J. Veale, E. Balogh, J. McCormick, S. NicAnUltaigh, M. Connolly, and U. Fearon Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis PLoS One 6 2011 e23540
31. U. Sachdev, X. Cui, G. Hong, S. Namkoong, J.M. Karlsson, C.J. Baty, and E. Tzeng High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury J. Vasc. Surg. 55 2012 180 191
32. W. Sekundo, A.J. Augustin, and I. Strempel Topical allopurinol or corticosteroids and acetylcysteine in the early treatment of experimental corneal alkali burns: a pilot study Eur. J. Ophthalmol. 12 2002 366 372
33. M. Takehara, M. Ueda, Y. Yamashita, Y. Terai, Y.C. Hung, and M. Ueki Vascular endothelial growth factor A and C gene expression in endometriosis Hum. Pathol. 35 2004 1369 1375
34. K. Taori, V.J. Paul, and H. Luesch Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp J. Am. Chem. Soc. 130 2008 1806 1807
35. A.D. van der Meer, K. Vermeul, A.A. Poot, J. Feijen, and I. Vermes A microfluidic wound-healing assay for quantifying endothelial cell migration Am. J. Physiol. Heart Circ. Physiol. 298 2010 H719 725
36. S. Wang, X. Li, M. Parra, E. Verdin, R. Bassel-Duby, and E.N. Olson Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7 Proc. Natl. Acad. Sci. U.S.A. 105 2008 7738 7743
37. Y. Ying, K. Taori, H. Kim, J. Hong, and H. Luesch Total synthesis and molecular target of largazole, a histone deacetylase inhibitor J. Am. Chem. Soc. 130 2008 8455 8459
38. X. Zeng, B. Yin, Z. Hu, C. Liao, J. Liu, S. Li, Z. Li, M.C. Nicklaus, G. Zhou, and S. Jiang Total synthesis and biological evaluation of largazole and derivatives with promising selectivity for cancers cells Org. Lett. 12 2010 1368 1371
39. B. Zhou, A. Margariti, L. Zeng, and Q. Xu Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis Cardiovasc. Res. 90 2011 413 420